A new study explains how pancreatic tumors use a sugar coating to hide from the immune system and shows that a newly ...

Add articles to your saved list and come back to them anytime. Almost exactly one year ago, then-year 12 graduate Kennedy Meddows nervously looked up her ATAR. Hoping to study architecture at the ...

Fetterman Slams Trump: ‘Do Not Threaten Members of Congress — Ever’ Taps may run dry in this country, where the water crisis is so severe it can be seen from space More than 9,000 cannabis plants ...

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Compass Pathways, which ...

Dr Vishal A. Patel discusses the design and patient criteria for the pivotal C-POST trial evaluating adjuvant cemiplimab in high-risk cutaneous squamous cell carcinoma. In an interview with Targeted ...

In recent years, hundreds of community colleges have embraced the guided pathways model, a sweeping set of large-scale reforms to better steer students through academic programs and boost completion ...

Vividion Therapeutics, Inc. (Vividion), a clinical-stage biopharmaceutical company, and a wholly owned and independently operated subsidiary of Bayer AG, today announced the publication of a ...

Low-dose aspirin significantly reduced colorectal cancer recurrence in patients with PI3K pathway gene alterations, nearly halving recurrence rates over three years compared to placebo. The study ...

June 28th, 1349 of the Epoch Calendar. Tingen City, Loen Kingdom. Time ticks as Tingen City’s Doomsday on September 9th gets ever closer. And this is the time and place Chinese youth Zhou Mingrui ...

A groundbreaking review published in Current Molecular Pharmacology sheds light on sarcopenia, a debilitating age-related muscle loss affecting millions globally. The study, led by Priyanka Prajapati ...

A new cancer drug candidate has demonstrated the ability to block tumor growth without triggering a common and debilitating side effect. The compound was developed by Lawrence Livermore National ...